首页 › 非霍奇金淋巴瘤 › 哥伦比亚特区 › Washington
Washington DC 非霍奇金淋巴瘤临床试验
18项针对 非霍奇金淋巴瘤的研究正在 Washington及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
招募中1/2 期
- American Oncology Partners of Maryland Pa, Bethesda · 距离 7 英里
CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
招募中1/2 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
招募中3 期
- GC2202 Study Site 111, Bethesda · 距离 7 英里
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
招募中1/2 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
招募中观察性研究
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Tissue Collection for Studies of Lymph Cancer
招募中观察性研究
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease
招募中2 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
招募中观察性研究欢迎健康志愿者
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
招募中2 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma
招募中观察性研究
- Walter Reed National Military Medical Center, Bethesda · 距离 7 英里
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
招募中1/2 期
- Medstar Georgetown University Hospital, Washington D.C.
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
招募中1/2 期
- Children's National Medical Center, Washington D.C.
Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
招募中1 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
招募中3 期
- American Oncology Partners of Maryland, PA, Bethesda · 距离 7 英里
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
招募中3 期
- MedStar Georgetown University Hospital, Washington D.C.
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
招募中观察性研究
- Children's National Medical Center, Washington D.C.
- Nih/Niaid, Bethesda · 距离 7 英里
- Nih/Nhlbi, Bethesda · 距离 7 英里
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
招募中1/2 期
- The Center for Cancer and Blood Disorders (CCBD), Bethesda · 距离 7 英里
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Silver Spring · 距离 7 英里
- Massive Bio SYNERGY-AI site, Bethesda · 距离 7 英里
其他城市的 非霍奇金淋巴瘤试验
- Houston, TX31 项研究
- New York City, NY31 项研究
- Boston, MA26 项研究
- Nashville, TN21 项研究
- Philadelphia, PA20 项研究
- Baldwin Park, CA19 项研究
- Atlanta, GA18 项研究
- Chicago, IL18 项研究
- Milwaukee, WI18 项研究
- Columbus, OH18 项研究
- Dallas, TX17 项研究
- Seattle, WA16 项研究
Washington的其他研究
- 癌症（所有类型）58 项研究
- 非小细胞肺癌55 项研究
- 乳腺癌46 项研究
- 转移性癌症43 项研究
- 肺癌41 项研究
- 前列腺癌38 项研究
- 肥胖症33 项研究
- 结直肠癌29 项研究
- 心血管疾病28 项研究
- 膀胱癌26 项研究
- 急性髓系白血病24 项研究
- 卵巢癌23 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。